DCGI grants permission to Serum Institute to manufacture its COVID-19 vaccine ‘Covishield’

Drugs Controller General of India grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’. The Pune-based company earlier stated that ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.

from IndiaTV: Google News Feed https://ift.tt/2MvTK56